Variations set for simplified process
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
The Heads of European Union Medicines Agencies’ (HMA’s) Regulatory Optimisation Group (ROG) has recommended a series of measures to simplify the process of filing Type IA variations.